Robert E. Wittes

4.0k total citations
42 papers, 2.0k citations indexed

About

Robert E. Wittes is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Robert E. Wittes has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Epidemiology. Recurrent topics in Robert E. Wittes's work include Lung Cancer Research Studies (8 papers), Neuroendocrine Tumor Research Advances (7 papers) and Head and Neck Cancer Studies (6 papers). Robert E. Wittes is often cited by papers focused on Lung Cancer Research Studies (8 papers), Neuroendocrine Tumor Research Advances (7 papers) and Head and Neck Cancer Studies (6 papers). Robert E. Wittes collaborates with scholars based in United States, Malaysia and Canada. Robert E. Wittes's co-authors include Robert B. Golbey, Brian Leyland‐Jones, Alfred L. Goldberg, Silvia Marsoni, Peter J. O’Dwyer, Esteban Cvitkovic, Janet Wittes, Ann Setser, Mark C. Willingham and Willet F. Whitmore and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Robert E. Wittes

42 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Wittes United States 21 922 618 468 379 320 42 2.0k
R. Wittes United States 25 1.5k 1.6× 473 0.8× 280 0.6× 692 1.8× 706 2.2× 51 2.7k
Gerrit DeBoer Canada 26 1.1k 1.2× 755 1.2× 513 1.1× 965 2.5× 142 0.4× 43 2.8k
Wendy Recant United States 23 972 1.1× 764 1.2× 539 1.2× 485 1.3× 502 1.6× 47 2.4k
Claes Silfverswärd Sweden 32 1.0k 1.1× 525 0.8× 785 1.7× 465 1.2× 608 1.9× 109 3.4k
S Hellman United States 13 806 0.9× 453 0.7× 325 0.7× 411 1.1× 359 1.1× 23 1.9k
Rose J. Papac United States 19 647 0.7× 373 0.6× 342 0.7× 377 1.0× 136 0.4× 49 1.5k
James K. Luce United States 23 1.1k 1.2× 485 0.8× 202 0.4× 560 1.5× 342 1.1× 33 2.0k
Andreas Schalhorn Germany 26 1.8k 2.0× 617 1.0× 699 1.5× 811 2.1× 255 0.8× 93 3.0k
John J. Costanzi United States 23 509 0.6× 371 0.6× 276 0.6× 280 0.7× 226 0.7× 56 1.5k
Annette Hogg Australia 32 887 1.0× 591 1.0× 496 1.1× 1.1k 3.0× 250 0.8× 50 3.1k

Countries citing papers authored by Robert E. Wittes

Since Specialization
Citations

This map shows the geographic impact of Robert E. Wittes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Wittes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Wittes more than expected).

Fields of papers citing papers by Robert E. Wittes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Wittes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Wittes. The network helps show where Robert E. Wittes may publish in the future.

Co-authorship network of co-authors of Robert E. Wittes

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Wittes. A scholar is included among the top collaborators of Robert E. Wittes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Wittes. Robert E. Wittes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, Wyndham H., Michael L. Grossbard, Stefania Pittaluga, et al.. (2002). Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy. Blood. 99(8). 2685–2693. 234 indexed citations
2.
Wittes, Robert E., et al.. (1999). SEVERE BACILLUS CALMETTE-GUERIN CYSTITIS RESPONDS TO SYSTEMIC STEROIDS WHEN ANTITUBERCULOUS DRUGS AND LOCAL STEROIDS FAIL. The Journal of Urology. 1568–1569. 2 indexed citations
3.
Pai, Lee H., Robert E. Wittes, Ann Setser, Mark C. Willingham, & Ira Pastan. (1996). Treatment of advanced solid tumors with immunotoxin LMB–1: An antibody linked to Pseudomonas exotoxin. Nature Medicine. 2(3). 350–353. 159 indexed citations
4.
Smet, Marc D. de, et al.. (1996). Intraocular Levels of Methotrexate After Intravenous Administration. American Journal of Ophthalmology. 121(4). 442–444. 43 indexed citations
5.
Wittes, Robert E.. (1995). Promoting synergism in an era of change. The American Journal of Medicine. 99(6). 87s–90s. 2 indexed citations
6.
Wittes, Robert E.. (1993). Small‐cell lung cancer: An overview of issues in therapy. Seminars in Surgical Oncology. 9(2). 127–134. 2 indexed citations
7.
Wittes, Robert E.. (1988). Manual of Oncologic Therapeutics, 1989/1990. Virtual Defense Library (Ministerio de Defensa). 2 indexed citations
8.
Leventhal, Brigid G. & Robert E. Wittes. (1988). Research Methods in Clinical Oncology. Medical Entomology and Zoology. 17 indexed citations
9.
Wittes, Robert E.. (1987). Problems in the medical interpretation of overviews. Statistics in Medicine. 6(3). 269–276. 36 indexed citations
10.
Perloff, Marjorie, et al.. (1986). Small cell bronchogenic carcinoma. Current Problems in Cancer. 10(4). 169–214. 7 indexed citations
11.
Wittes, Robert E., et al.. (1984). PROBLEMS IN THE THERAPY OF AIDS‐ASSOCIATED MALIGNANCIES. Annals of the New York Academy of Sciences. 437(1). 454–460. 4 indexed citations
12.
Wittes, Robert E.. (1980). Chemotherapy of Head and Neck Cancer. Otolaryngologic Clinics of North America. 13(3). 515–520. 49 indexed citations
13.
Hilaris, Basil S., et al.. (1980). Small cell carcinoma of the lung experience with a six-drug regimen. Cancer. 45(3). 417–422. 13 indexed citations
14.
Charles, Norman C., et al.. (1980). Carcinoma metastatic to the anterior ocular segment: Response to chemotherapy. Cancer. 45(10). 2521–2523. 12 indexed citations
15.
Wittes, Robert E., et al.. (1978). Weekly administration of cis-diamminedichloroplatinum (II) without hydration or osmotic diuresis. European Journal of Cancer (1965). 14(7). 753–756. 18 indexed citations
16.
Vallejo, Alvaro, Ronald H. Spiro, Jatin P. Shah, et al.. (1978). Combination therapy of advanced head and neck cancer.Induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy. Cancer. 41(2). 460–467. 148 indexed citations
17.
Wittes, Robert E., Seymour Hopfan, Basil S. Hilaris, et al.. (1977). Oat cell carcinoma of the lung.Combination treatment with radiotherapy and cyclophosphamide, adriamycin, vincristine, and methotrexate. Cancer. 40(2). 653–659. 29 indexed citations
18.
Wittes, Robert E.. (1977). Indications for Liver and Brain Scans. JAMA. 238(6). 506–506. 15 indexed citations
19.
Wittes, Robert E., Alan Yagoda, Gordon B. Magill, et al.. (1976). Chemotherapy of germ cell tumors of the testis. I. Induction of remissions with vinblastine, actinomycin D, and bleomycin. Cancer. 37(2). 637–645. 69 indexed citations
20.
Goldberg, Alfred L. & Robert E. Wittes. (1966). Genetic Code: Aspects of Organization. Science. 153(3734). 420–424. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026